Assessment of Whole Blood Cold Stored Platelets
NCT02006368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2017-08-04
Summary
The purpose of this study is to determine the life span and functional characteristics of platelets derived from whole blood that has been stored in a refrigerator for up to 21 days. Currently, platelets are separated from red cells shortly after donation and stored at room temperature for no longer than 5 days. This study is considered experimental because; 1) we will be keeping platelets in the original whole blood donor unit in the refrigerator, and 2) we will be reinfusing a small portion of that donation back into the study-subject-donor and tracking how many of the transfused platelets from that unit circulate in the study-subject-donor in the hours and days after transfusion.
Conditions
- Healthy
Interventions
- OTHER
-
Blood Collection and autologous re-infusion
Subjects will donate one unit of whole blood. This unit will be stored at 4°C for a predefined storage period. A variety of in vitro metabolic and functional platelet assays will be performed on the stored unit. After the storage period, an aliquot from the whole blood unit will be processed to obtain platelets. The subject will return and donate a fresh sample of whole blood (43 mls) from which a fresh aliquot of platelets will be obtained. The stored and fresh platelets will each be labeled with a different radioisotope (either Chromium-51 or Indium-111) and reinfused into the subject. Using two different radioisotopes enables separate tracking of both the stored and fresh platelets. Follow-up blood samples will be drawn at 2 hours and on days 1, 2, 3, 5, 7±1 and 10±2. Stored and Fresh platelet recoveries and survivals will be calculated.
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
Bloodworks
lead OTHER
Principal Investigators
-
Sherrill J Slichter, MD · Puget Sound Blood Center & University of Washington
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- United States
Study Locations
More Related Trials
-
The SOLID Platelet Study
NCT03712618 ·Status: TERMINATED ·Phase: PHASE2
-
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
NCT06824727 ·Status: COMPLETED
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Combined Platelet Transfusion
NCT06613425 ·Status: RECRUITING ·Phase: PHASE4
-
Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
NCT02032134 ·Status: TERMINATED ·Phase: PHASE4
-
Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
NCT05628974 ·Status: RECRUITING
-
Post-transfusion Platelet Count
NCT02601131 ·Status: COMPLETED
-
Study of Constitutional Platelet Disease
NCT04419987 ·Status: UNKNOWN ·Phase: NA
-
Platelet Volunteers, Longitudinal and Multi-omic Study
NCT07137429 ·Status: RECRUITING
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution
NCT02145507 ·Status: COMPLETED ·Phase: PHASE1
-
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
NCT01386723 ·Status: TERMINATED
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Survival and Recovery of Radio-labeled Platelets Derived From Mirasol-treated Whole Blood
NCT02330081 ·Status: COMPLETED ·Phase: NA
-
Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers
NCT00031174 ·Status: TERMINATED
-
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 ·Status: RECRUITING ·Phase: NA
-
Biologic Characterization of Patients With ITP
NCT05694325 ·Status: RECRUITING ·Phase: NA
-
Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients
NCT05067608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Platelet Products Tested With the ThromboLUX® Platelet Quality Test
NCT02158416 ·Status: COMPLETED
-
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
NCT00128713 ·Status: COMPLETED ·Phase: PHASE3
-
Calculation of Platelet-rich Plasma Preparation Yield
NCT03161743 ·Status: UNKNOWN
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05985668 ·Status: RECRUITING
-
Italian Platelet Technology Assessment Study
NCT01642563 ·Status: TERMINATED ·Phase: PHASE3
-
Thrombopoietin Levels and Platelet Transfusion in Neonates
NCT00549484 ·Status: COMPLETED